Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Avidity Biosciences, Inc. Common Stock (RNA)

Novartis acquires Avidity Biosciences for $12B, strengthening its rare disease pipeline with RNA-based therapies. The deal is expected to close in the first half of 2026.

### About Avidity Biosciences, Inc. Common Stock
Avidity Biosciences, Inc. is a biopharmaceutical company focused on developing RNA-based therapeutics.  
Avidity Biosciences, Inc. Common Stock uses the ticker $RNA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Avidity Biosciences, Inc. Common Stock (RNA) trading volume is up XXXXX% from the previous week.
- Avidity Biosciences, Inc. Common Stock (RNA) social dominance is up XXXXXX% from the previous X months.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$rna/time-series/close.tsv)  
The stock price is nearing its 52-week high, driven by the news of the Novartis acquisition which offers a significant premium, leading to increased trading volume and positive sentiment.  

24-Hour: XXXX%
7-Day: -XXX%
30-Day: XXXX%

1-Year High: $XXXXX on 2025-11-28  
1-Year Low: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$rna/time-series/alt_rank.tsv)  
Avidity Biosciences, Inc. Common Stock (RNA) is currently AltRank #619 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XXX  
X Month: XXX +144  
X Months: XXX -XXX  
X Year: XXX +526  
1-Year High: XXXXX on 2025-06-28  
1-Year Low: XX on 2024-12-21  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rna/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2025-08-06  
1-Year Low: XX on 2025-05-11  
  
  
### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rna/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +7.20%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +260%  
X Year: XXXXXXXXX +29%  
1-Year High: XXXXXXX on 2025-10-26  
1-Year Low: XXX on 2025-06-15  

Engagements by network (24h):
Reddit: XXX
X: XXXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rna/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +131%  
X Year: XXXXX +63%  
1-Year High: XXXXX on 2025-10-28  
1-Year Low: XX on 2025-05-03  

Mentions by network (24h):
Reddit: XX
X: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rna/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Avidity Biosciences, Inc. Common Stock (RNA) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +259%  
X Year: XXXXX +124%  
1-Year High: XXX on 2025-10-28  
1-Year Low: XX on 2025-05-03  

The most influential creators that mention Avidity Biosciences, Inc. Common Stock in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@PersimmonTI](/creator/twitter/PersimmonTI)       | X    | XXXXXX    | X     | XXXXX       |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)       | X    | XXXXXX    | XX    | XXXXX       |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)         | X    | XX        | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)   | X    | XXXXX     | X     | XXX         |
| [@Hall8Jack](/creator/twitter/Hall8Jack)           | X    | XXXXX     | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)         | X    | XXXXXX    | X     | XXX         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)     | X    | XXXXX     | X     | XXX         |
| [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) | X    | XXXXXX    | X     | XXX         |
| [@AnotherBio](/creator/twitter/AnotherBio)         | X    | XXXXX     | X     | XX          |
| [@seedytx19](/creator/twitter/seedytx19)           | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$rna/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rna/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% +6%  
X Months: XX% -XX%  
X Year: XX% -X%  
1-Year High: XXX% on 2025-02-21  
1-Year Low: XX% on 2025-12-07  

Most Supportive Themes:
- Novartis Acquisition: (80%) Novartis is acquiring Avidity Biosciences for $XX billion, significantly bolstering its rare disease pipeline with Avidity's RNA-based therapies.
- RNA Therapeutics Pipeline: (15%) Avidity's proprietary Antibody Oligonucleotide Conjugates (AOCs) platform and late-stage RNA therapies are key assets driving the acquisition.
  
Most Critical Themes:
- Clinical Holds and Discontinuations: (5%) Concerns exist regarding potential clinical holds and discontinuations in related RNA therapies, which could impact future developments.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$rna/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXX%  
X Week: XXXXX% +0.011%  
X Month: XXXXX% +0.014%  
X Months: XXXXX% +0.026%  
X Year: XXXXX% -XXXX%  
1-Year High: XXXXX% on 2025-10-28  
1-Year Low: XXXXXX% on 2025-05-13  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$rna/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-12-02  
1-Year Low: XXXXXX% on 2025-03-11  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$rna/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX -$0.34%  
X Month: $XXXXXXXXXXXXXX +$2.10%  
X Months: $XXXXXXXXXXXXXX +$184%  
X Year: $XXXXXXXXXXXXXX +$149%  
1-Year High: $XXXXXXXXXXXXXX on 2025-11-28  
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08  

### Top Avidity Biosciences, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$dyn DMD data and capital raise set foundation for critical talks at #JPM26. It's either pay $9B now or wait for DM1 readout and pay double*. Novartis CEO said they would have had to pay double (2*$12B) for $RNA if they had waited for DM1 results. I believe $dyn DM1 drug superior to $rna based on splicing index"  
[X Link](https://x.com/RNAiAnalyst/status/1998674373914296574) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2025-12-10T08:41Z 20.8K followers, 2238 engagements


"Buy Signal Avidity Biosciences Inc - X Dec 2025 @ 15:07 - USD71.39"  
[Reddit Link](https://redd.it/1pihtgx) [@jvc72](/creator/reddit/jvc72) 2025-12-09T20:39Z X followers, X engagements


"ive got a good feeling about $VERV and $RNA. im thinking $LLY and $NVS"  
[X Link](https://x.com/PersimmonTI/status/1998484020724904215) [@PersimmonTI](/creator/x/PersimmonTI) 2025-12-09T20:04Z 10.5K followers, 6772 engagements


"This is amazing tech $RGP $RGTI $RIBT $RIGL $RKDA $RLYB $RNA $RNXT $ROCL $ROIV $RONI $ROSE $ROYL $RRAC $RSLS $RTRY $RUSHA $RVAC $RVMD $RVNC $RXRX $RYTM $SABS $SAI $SALM $SAMA $SAN $SANA $SATL $SATX $SBFM $SBIG $SBNY $SBTX $SCOR $SDA $SDIG $SEAC $SECO $SEDA"  
[X Link](https://x.com/BuyTheUgly/status/1998480736152613066) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T19:51Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Avidity Biosciences, Inc. Common Stock (RNA)

Novartis acquires Avidity Biosciences for $12B, strengthening its rare disease pipeline with RNA-based therapies. The deal is expected to close in the first half of 2026.

About Avidity Biosciences, Inc. Common Stock

Avidity Biosciences, Inc. is a biopharmaceutical company focused on developing RNA-based therapeutics.
Avidity Biosciences, Inc. Common Stock uses the ticker $RNA for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Avidity Biosciences, Inc. Common Stock (RNA) trading volume is up XXXXX% from the previous week.
  • Avidity Biosciences, Inc. Common Stock (RNA) social dominance is up XXXXXX% from the previous X months.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is nearing its 52-week high, driven by the news of the Novartis acquisition which offers a significant premium, leading to increased trading volume and positive sentiment.

24-Hour: XXXX% 7-Day: -XXX% 30-Day: XXXX%

1-Year High: $XXXXX on 2025-11-28
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Avidity Biosciences, Inc. Common Stock (RNA) is currently AltRank #619 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
X Month: XXX +144
X Months: XXX -XXX
X Year: XXX +526
1-Year High: XXXXX on 2025-06-28
1-Year Low: XX on 2024-12-21

Galaxy Score: XX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-08-06
1-Year Low: XX on 2025-05-11

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +7.20%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +260%
X Year: XXXXXXXXX +29%
1-Year High: XXXXXXX on 2025-10-26
1-Year Low: XXX on 2025-06-15

Engagements by network (24h): Reddit: XXX X: XXXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +131%
X Year: XXXXX +63%
1-Year High: XXXXX on 2025-10-28
1-Year Low: XX on 2025-05-03

Mentions by network (24h): Reddit: XX X: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Avidity Biosciences, Inc. Common Stock (RNA) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +259%
X Year: XXXXX +124%
1-Year High: XXX on 2025-10-28
1-Year Low: XX on 2025-05-03

The most influential creators that mention Avidity Biosciences, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@PersimmonTI X XXXXXX X XXXXX
@RNAiAnalyst X XXXXXX XX XXXXX
@BuyTheUgly X XX X XXX
@bioinvestor24 X XXXXX X XXX
@Hall8Jack X XXXXX X XXX
@BiopharmIQ X XXXXXX X XXX
@JoseRestonVA X XXXXX X XXX
@BowTiedBiotech X XXXXXX X XXX
@AnotherBio X XXXXX X XX
@seedytx19 XX XXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% +6%
X Months: XX% -XX%
X Year: XX% -X%
1-Year High: XXX% on 2025-02-21
1-Year Low: XX% on 2025-12-07

Most Supportive Themes:

  • Novartis Acquisition: (80%) Novartis is acquiring Avidity Biosciences for $XX billion, significantly bolstering its rare disease pipeline with Avidity's RNA-based therapies.
  • RNA Therapeutics Pipeline: (15%) Avidity's proprietary Antibody Oligonucleotide Conjugates (AOCs) platform and late-stage RNA therapies are key assets driving the acquisition.

Most Critical Themes:

  • Clinical Holds and Discontinuations: (5%) Concerns exist regarding potential clinical holds and discontinuations in related RNA therapies, which could impact future developments.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXX%
X Week: XXXXX% +0.011%
X Month: XXXXX% +0.014%
X Months: XXXXX% +0.026%
X Year: XXXXX% -XXXX%
1-Year High: XXXXX% on 2025-10-28
1-Year Low: XXXXXX% on 2025-05-13

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-12-02
1-Year Low: XXXXXX% on 2025-03-11

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$0.34%
X Month: $XXXXXXXXXXXXXX +$2.10%
X Months: $XXXXXXXXXXXXXX +$184%
X Year: $XXXXXXXXXXXXXX +$149%
1-Year High: $XXXXXXXXXXXXXX on 2025-11-28
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top Avidity Biosciences, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$dyn DMD data and capital raise set foundation for critical talks at #JPM26. It's either pay $9B now or wait for DM1 readout and pay double*. Novartis CEO said they would have had to pay double (2*$12B) for $RNA if they had waited for DM1 results. I believe $dyn DM1 drug superior to $rna based on splicing index"
X Link @RNAiAnalyst 2025-12-10T08:41Z 20.8K followers, 2238 engagements

"Buy Signal Avidity Biosciences Inc - X Dec 2025 @ 15:07 - USD71.39"
Reddit Link @jvc72 2025-12-09T20:39Z X followers, X engagements

"ive got a good feeling about $VERV and $RNA. im thinking $LLY and $NVS"
X Link @PersimmonTI 2025-12-09T20:04Z 10.5K followers, 6772 engagements

"This is amazing tech $RGP $RGTI $RIBT $RIGL $RKDA $RLYB $RNA $RNXT $ROCL $ROIV $RONI $ROSE $ROYL $RRAC $RSLS $RTRY $RUSHA $RVAC $RVMD $RVNC $RXRX $RYTM $SABS $SAI $SALM $SAMA $SAN $SANA $SATL $SATX $SBFM $SBIG $SBNY $SBTX $SCOR $SDA $SDIG $SEAC $SECO $SEDA"
X Link @BuyTheUgly 2025-12-09T19:51Z XX followers, XXX engagements

Avidity Biosciences, Inc. Common Stock (RNA)
/topic/$rna